Financial Life Planners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.6K Buy
617
+14
+2% +$602 0.02% 161
2026
Q1
$22.2K Buy
+603
New +$28.6K 0.02% 181
2025
Q4
Sell
-603
Closed -$33.5K 245
2025
Q3
$33.5K Buy
+603
New +$35.3K 0.02% 158
2025
Q1
Sell
-591
Closed -$50.8K 283
2024
Q4
$50.8K Buy
+591
New +$63.9K 0.04% 116

Other funds holding NVO

Financial Life Planners's NVO Position: Q2 2026 in Review

Financial Life Planners increased its Novo Nordisk (NVO) stake by 2.3% in Q2 2026, buying an estimated $602 and bringing the position to 617 shares worth $29.6K. The position accounts for 0.02% of the portfolio, ranked #161.

Financial Life Planners first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $50.8K in Q4 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Financial Life Planners held 617 shares of Novo Nordisk worth $29.6K as of Q2 2026.
  • Financial Life Planners bought 14 Novo Nordisk shares in Q2 2026, an estimated $602.
  • Novo Nordisk made up 0.02% of Financial Life Planners's portfolio in Q2 2026, its #161 holding.
  • Financial Life Planners first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • Financial Life Planners's Novo Nordisk position peaked at $50.8K in Q4 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Life Planners's 13F filing for Q2 2026, filed 21 Jul 2026.